Genesystem진시스템
363250 · KOSDAQ · ₩363250 · 진시스템
₩4,340▲ ₩315 (7.83%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | −198.8% | −646.3% | −150.7% | −176.8% | 32.0% | 65.5% |
| Operating margin | −777.4% | −2,541.0% | −837.6% | −1,057.3% | −180.8% | 17.1% |
| Net margin | −1,018.0% | −3,135.0% | −738.2% | −882.4% | −246.3% | 26.8% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +164.9% | −68.4% | +34.6% | −75.4% | −72.4% | — |
| Operating income growth | +19.0% | +4.2% | −6.7% | −43.6% | −391.5% | — |
| Net income growth | +14.0% | −34.1% | −12.6% | +12.0% | −353.3% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −104.6% | −88.2% | −38.2% | −25.3% | −22.7% | 8.1% |
| Return on assets | −79.3% | −66.2% | −27.7% | −20.1% | −19.6% | 7.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 51.9% | 85.8% | 36.7% | 26.9% | 17.3% | 14.9% |
| Net debt to equity | −2.9% | 34.0% | −16.4% | −32.7% | −36.7% | −49.2% |
| Current ratio | 359.3% | 108.2% | 393.3% | 865.2% | 1,549.5% | 1,570.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Genesystem / 진시스템 / 363250 / KRX:363250
Source: KRX statistical information